ArticleCritical care explorations2026
Aerosol Delivery With a Vibrating Mesh Nebulizer Across Tidal Volume-Based Pediatric Invasive Ventilation Models: An In Vitro Evaluation.
Article in Critical care explorations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextDespite the widespread use of vibrating mesh nebulizers (VMNs) for aerosol therapy during mechanical ventilation, there is limited pediatric evidence on how tidal volume (TV)-based ventilation models and commonly modified ventilator- and circuit-related factors affect aerosol delivery. HYPOTHESIS: We hypothesized that these ventilator- and circuit-related modifications would affect the efficacy of aerosol delivery with a VMN. METHODS AND MODELS: We conducted an in vitro experiment using six pediatric ventilation models with TVs set at 8 mL/kg (TV: 40-400 mL for 5-50 kg), representing children from infancy to adolescence. We nebulized salbutamol with a VMN positioned on the dry side of a heated humidifier, and quantified inhaled mass fraction by measuring the drug collected on a filter positioned distal to the endotracheal tube using a spectrophotometer. We evaluated the effects of TV-based models and variations in other settings, including endotracheal tube sizes, bias flows, inspiratory rise time, ventilator modes, circuit configurations, VMN positions, and drug concentrations.
resultsIn the baseline model with a TV of 80 mL, the mean ± sd of inhaled mass fraction was 11.2% ± 0.3%. It increased progressively across the TV-based models: 3.5% ± 0.2% (TV: 40 mL), 7.9% ± 0.4% (TV: 56 mL), 15.7% ± 0.2% (TV: 120 mL), 19.4% ± 0.4% (TV: 160 mL), and 21.3% ± 1.7% (TV: 400 mL; all INTERPRETATION AND
conclusionsVMN aerosol delivery increased across TV-based ventilation models and was minimally affected by other ventilator settings, endotracheal tube size, and circuit-related modifications. Consistent aerosol delivery at a given TV suggests that TV is the dominant determinant of aerosol delivery efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.